Solar  -  April 28, 2022

GlaxoSmithKline Consumer Healthcare Adds NY Solar

GlaxoSmithKline (GSK) Consumer Healthcare announced the completion of a solar panel project to serve GSK Consumer Healthcare’s Oak Hill, New York site in April. 

The project enables GSK Consumer Healthcare to reduce its carbon emissions and is located in the scenic Catskill Mountains. The solar project comprises over 17,000 modules with an estimated electricity generation capacity of 6.9 MW DC. This installation is designed to generate electricity equivalent to more than 70% of the Oak Hill site’s annual usage and reduce its carbon footprint by 60%.

“The completion of this project marks a pivotal moment for us at GSK Consumer Healthcare, as a continued step in the right direction for enacting real change that reduces our environmental impact and helps us deliver on our larger sustainability initiatives,” said Mike Allen, Sustainability Lead Consumer Health Supply Chain, GSK Consumer Healthcare, in a statement. “The Oak Hill site is the 12th solar investment project for GSK and our Consumer Healthcare business, and we plan to implement additional major solar and wind energy investments in the UK and US to set us on track for 100% renewable electricity by 2025.”

As the designated off-taker of the clean energy generated at the solar site, the project will support GSK Consumer Healthcare’s goal to reduce its Scope 1 and 2 carbon emissions by 100% by 2030.